GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Future 3-5Y EPS without NRI Growth Rate

XBiotech (STU:4XB) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Sep. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, XBiotech's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of XBiotech's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, XBiotech's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XBiotech's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XBiotech's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where XBiotech's Future 3-5Y EPS without NRI Growth Rate falls into.



XBiotech  (STU:4XB) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


XBiotech Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of XBiotech's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


XBiotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech Headlines

No Headlines